Inter Pharma Public Company Limited (BKK: IP)

Market Cap	2.40B
Revenue (ttm)	1.81B
Net Income (ttm)	20.39M
Shares Out	605.34M
EPS (ttm)	0.03
PE Ratio	117.54
Forward PE	n/a
Dividend	0.02 (0.54%)
Ex-Dividend Date	May 7, 2024

Volume	1,237,933
Open	3.980
Previous Close	4.000
Day's Range	3.940 - 4.020
52-Week Range	3.300 - 11.100
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About IP

Inter Pharma Public Company Limited manufactures, imports, and distributes dietary supplement products for humans and animals in Thailand. It operates through three: Human Healthcare, Animal Healthcare, and Hospital segments. The company offers human, anti-aging, and human products, such as medical supplies, nutrition therapy, cosmetics, supplementary foods, probiotic and prebiotic products, health food products, general food products, medical equipment and medicines, etc.; functional foods and drinks; and pharmaceutical products; It also provi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: IP

Financial Performance

In 2023, IP's revenue was 1.80 billion, an increase of 17.23% compared to the previous year's 1.53 billion. Earnings were 50.79 million, a decrease of -57.28%.